Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series.
Shi VY, Tran K, Patel F, Leventhal J, Konia T, Fung MA, Wilken R, Garcia MS, Fitzmaurice SD, Joo J, Monjazeb AM, Burrall BA, King B, Martinez S, Christensen SD, Maverakis E. Shi VY, et al. J Am Acad Dermatol. 2015 Oct;73(4):645-54. doi: 10.1016/j.jaad.2015.06.060. Epub 2015 Aug 7. J Am Acad Dermatol. 2015. PMID: 26259990 Free article.
Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.
Siegel J, Totonchy M, Damsky W, Berk-Krauss J, Castiglione F Jr, Sznol M, Petrylak DP, Fischbach N, Goldberg SB, Decker RH, Stamatouli AM, Hafez N, Glusac EJ, Tomayko MM, Leventhal JS. Siegel J, et al. Among authors: leventhal js. J Am Acad Dermatol. 2018 Dec;79(6):1081-1088. doi: 10.1016/j.jaad.2018.07.008. Epub 2018 Jul 17. J Am Acad Dermatol. 2018. PMID: 30025829
Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.
Coleman E, Ko C, Dai F, Tomayko MM, Kluger H, Leventhal JS. Coleman E, et al. Among authors: leventhal js. J Am Acad Dermatol. 2019 Apr;80(4):990-997. doi: 10.1016/j.jaad.2018.10.062. Epub 2018 Nov 3. J Am Acad Dermatol. 2019. PMID: 30399387 Free PMC article.
Second-Hit, Postzygotic PMVK and MVD Mutations in Linear Porokeratosis.
Atzmony L, Khan HM, Lim YH, Paller AS, Levinsohn JL, Holland KE, Mirza FN, Yin E, Ko CJ, Leventhal JS, Choate KA. Atzmony L, et al. Among authors: leventhal js. JAMA Dermatol. 2019 May 1;155(5):548-555. doi: 10.1001/jamadermatol.2019.0016. JAMA Dermatol. 2019. PMID: 30942823 Free PMC article.
Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth factor receptor inhibitors: An assessment of topical timolol and the need for multiple medical and procedural therapies.
Olamiju B, Bhullar S, Coleman EL, Leventhal JS. Olamiju B, et al. Among authors: leventhal js. J Am Acad Dermatol. 2021 Mar;84(3):806-808. doi: 10.1016/j.jaad.2020.06.010. Epub 2020 Jun 11. J Am Acad Dermatol. 2021. PMID: 32526318 No abstract available.
Association between halo nevi and melanoma in adults: A multicenter retrospective case series.
Haynes D, Strunck JL, Said J, Tam I, Varedi A, Topham CA, Olamiju B, Wei BM, Erickson MK, Wang LL, Tan A, Stoner R, Hartman RI, Lilly E, Grossman D, Curtis JA, Westerdahl JS, Leventhal JS, Choi JN, Chu EY, Ming ME, Stein JA, Liebman TN, Berry E, Greiling TM. Haynes D, et al. Among authors: leventhal js. J Am Acad Dermatol. 2021 Apr;84(4):1164-1166. doi: 10.1016/j.jaad.2020.08.056. Epub 2020 Aug 18. J Am Acad Dermatol. 2021. PMID: 32822787 No abstract available.
123 results